Sanofi (NASDAQ: SNY) was upgraded by analysts at Liberum Capital from a "hold" rating to a "buy" rating.
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitorsGlobeNewswire
- China's Xi Jinping goes on charm offensive days before Trump unveils fresh tariffs [CNN]CNN
- China's Xi Jinping goes on charm offensive days before Trump unveils fresh tariffs [CNN]CNN
- Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDGlobeNewswire
- Male Fertility Industry Analysis 2019-2034: Trends, Shares and Projections by Test Type, Treatment Type, Supplement, End User and Region [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 3/27/25 - Form S-8
- 3/26/25 - Form 6-K
- 3/21/25 - Form S-8
- SNY's page on the SEC website